Literature DB >> 20551105

Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis.

Giovanni Filocamo1, Sergio Davì, Angela Pistorio, Marta Bertamino, Nicolino Ruperto, Bianca Lattanzi, Alessandro Consolaro, Silvia Magni-Manzoni, Roberta Galasso, Giulia Camilla Varnier, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To evaluate the measurement properties of 21-numbered circle visual analog scales (VAS) and traditional 10-cm horizontal line VAS for physician and parent subjective ratings in children with juvenile idiopathic arthritis (JIA).
METHODS: We studied 2 patient samples in whom physician global rating of overall disease activity, parent global rating of the child's overall well-being, and parent rating of intensity of child's pain were performed using traditional 10-cm horizontal line VAS (n = 397) or 21-numbered circle VAS (n = 471). The measurement performances of the 2 VAS formats were examined by assessing construct validity, score distribution, responsiveness to change over time, and minimal clinically important difference (MCID).
RESULTS: Most Spearman correlations with other JIA outcome measures yielded by 21-numbered circle VAS were greater than those obtained with 10-cm horizontal line VAS, revealing that the circle VAS format has better construct validity. Ceiling effects (i.e., score = 0) for physician and parent global ratings were 43.7% and 32.9%, respectively, on 21-numbered circle VAS, and 31.6% and 35.3%, respectively, on 10-cm horizontal line VAS. Responsiveness of 21-numbered circle VAS was good (standardized response mean > 0.8) or moderate (standardized response mean > 0.6) among patients classified as improved or worsened, respectively, by the physician or the parent. Overall, MCID values for 21-numbered circle VAS tended to be greater for worsening than for improvement.
CONCLUSION: The 21-numbered circle VAS are a suitable alternative to the 10-cm horizontal line VAS and may facilitate incorporation of physician and parent subjective ratings in standard clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 20551105     DOI: 10.3899/jrheum.091474

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  73 in total

1.  Paediatric rheumatic disease: What is the best definition of clinical remission in JIA?

Authors:  Gabriella Giancane; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

Review 2.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer E Weiss; Nadia J C Luca; Alexis Boneparth; Jennifer Stinson
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

3.  Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.

Authors:  Daniel J Lovell; Murray H Passo; Timothy Beukelman; Suzanne L Bowyer; Beth S Gottlieb; Michael Henrickson; Norman T Ilowite; Yukiko Kimura; Esi Morgan DeWitt; Jill Segerman; Leonard D Stein; Janalee Taylor; Richard K Vehe; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

Review 4.  Criteria to define response to therapy in paediatric rheumatic diseases.

Authors:  Nicolino Ruperto; Angela Pistorio; Angelo Ravelli; Rachana Hasija; Dinara Guseinova; Giovanni Filocamo; Erkan Demirkaya; Clara Malattia; Alberto Martini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-20       Impact factor: 2.953

Review 5.  Juvenile idiopathic arthritis.

Authors:  Alberto Martini; Daniel J Lovell; Salvatore Albani; Hermine I Brunner; Kimme L Hyrich; Susan D Thompson; Nicolino Ruperto
Journal:  Nat Rev Dis Primers       Date:  2022-01-27       Impact factor: 65.038

6.  Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Authors:  Daniel J Lovell; Anne L Johnson; Bin Huang; Beth S Gottlieb; Paula W Morris; Yukiko Kimura; Karen Onel; Suzanne C Li; Alexei A Grom; Janalee Taylor; Hermine I Brunner; Jennifer L Huggins; James J Nocton; Kathleen A Haines; Barbara S Edelheit; Michael Shishov; Lawrence K Jung; Calvin B Williams; Melissa S Tesher; Denise M Costanzo; Lawrence S Zemel; Jason A Dare; Murray H Passo; Kaleo C Ede; Judyann C Olson; Elaine A Cassidy; Thomas A Griffin; Linda Wagner-Weiner; Jennifer E Weiss; Larry B Vogler; Kelly A Rouster-Stevens; Timothy Beukelman; Randy Q Cron; Daniel Kietz; Kenneth Schikler; Kara M Schmidt; Jay Mehta; Dawn M Wahezi; Tracy V Ting; James W Verbsky; B Anne Eberhard; Steven Spalding; Chen Chen; Edward H Giannini
Journal:  Arthritis Rheumatol       Date:  2018-07-25       Impact factor: 10.995

7.  The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.

Authors:  Dragana Lazarevic; Angela Pistorio; Elena Palmisani; Paivi Miettunen; Angelo Ravelli; Clarissa Pilkington; Nico M Wulffraat; Clara Malattia; Stella Maris Garay; Michael Hofer; Pierre Quartier; Pavla Dolezalova; Inmaculada Calvo Penades; Virginia P L Ferriani; Gerd Ganser; Ozgur Kasapcopur; Jose Antonio Melo-Gomes; Ann M Reed; Malgorzata Wierzbowska; Lisa G Rider; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

8.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

9.  Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes.

Authors:  Maryam Piram; Isabelle Koné-Paut; Helen J Lachmann; Joost Frenkel; Seza Ozen; Jasmin Kuemmerle-Deschner; Silvia Stojanov; Anna Simon; Martina Finetti; Maria Pia Sormani; Alberto Martini; Marco Gattorno; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2013-09-11       Impact factor: 19.103

Review 10.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.